Siglec-7 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Siglec-7 monoclonal antibodies for research in understanding this important immune regulatory protein. Siglec-7 Antibodies are validated for various techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Siglec-7, a member of the sialic acid-binding immunoglobulin-like lectin family, plays a crucial role in regulating immune responses and modulating cell signaling. It is primarily expressed on natural killer (NK) cells and some myeloid cells, where it contributes to the inhibition of immune activation and the maintenance of immune tolerance. Understanding Siglec-7 function is vital for elucidating potential implications in cancer immunotherapy and autoimmune diseases. Researchers can explore immune regulation mechanisms through specific detection and characterization of Siglec-7 expression patterns. Advanced research techniques supported by monoclonal antibodies enable detailed investigation of Siglec-7's role in cellular processes. Multiple validated applications provide flexibility in experimental design and data verification. Santa Cruz Biotechnology monoclonal antibodies for Siglec-7 support researchers worldwide in advancing our understanding of immune system regulation and potential therapeutic applications.